JEAN JACQUES LEFRÈRE, M.D.; DANIELLE GOZIN, Ph.D.; JACQUES MODAI, M.D.; DANIEL VITTECOQ, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: The prevalence of circulating anticoagulants has previously been reported to be high in patients with the acquired immunodeficiency syndrome (AIDS), particularly in those with Pneumocystis carinii pneumonia (1, 2). We report the findings of a prospective study on this subject.
During a 6-month period, 25 nonhemophiliac patients with AIDS (23 homosexual men, 1 drug addict, and 1 person who had received a blood transfusion) who fulfilled the Centers for Disease Control criteria, were included in the study. Ages ranged from 21 to 42 years (mean, 32). All had a markedly decreased T4/T8 ratio (mean, 0.12) and low
LEFRÈRE JJ, GOZIN D, MODAI J, et al. Circulating Anticoagulant in the Acquired Immunodeficiency Syndrome. Ann Intern Med. 1987;107:429–430. doi: 10.7326/0003-4819-107-2-429_2
Download citation file:
Published: Ann Intern Med. 1987;107(3):429-430.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use